Abstract:Purpose of review Over the past decades, visceral transplantation has become the standard of care for patients with irreversible intestinal failure who suffer complications of total parenteral nutrition (TPN). Graft-versus-host disease (GVHD) after solid organ transplantation is a rare but often fatal complication with high mortality. GVHD after intestinal transplantation , given the large lymphoid content of the graft, is more frequent compared with other solid organs. It is a complex condition that may have varied clinical presentations. The therapy of GVHD is multifactorial and has evolved with visceral transplantation . Recent findings In recent large series of intestinal transplantation performed in centers around the world, GVHD remained an important cause of death (40–70%). Advances in immunology and current treatment options come from the hematopoietic stem-cell transplantation (HSCT) experience given the high prevalence of GVHD in that patient population. Therapeutic options for GVHD are based on disease classification, overall grading, organs involved, and associated symptoms. Summary Graft-versus-host disease (GVHD) is a serious complication that can occur after solid organ and allogenic HSCT. Intestinal or multivisceral transplantation have the highest incidence of GVHD among all solid organ transplants with very high mortality rates. Increased risk of GVHD is present after multivisceral and liver-included transplants compared with isolated intestinal transplant. Visceral transplantation is the all-encompassing term used for transplant that includes small bowel. It includes isolated small bowel transplant, small bowel/pancreas transplant, liver/small bowel/ pancreas transplant, stomach/pancreas/small bowel (modified multivisceral transplant), and stomach/liver/pancreas/small bowel (multivisceral). Each of these may or may not include the colon as part of the allograft. Steroids remain the first line of treatment along with modulation of the primary immunosuppression . Steroid-refractory patients remain a challenge and, to date, no consensus has been achieved for a single agent second-line therapy. Successful outcome depends on early diagnosis and prompt treatment.

The Current Status of Multivisceral Transplantation

Orthotopic Abdominal Multivisceral Transplantation Without Venovenous Bypass in Pigs

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Long-term survival, nutritional autonomy, and quality of life after intestinal and multivisceral transplantation

Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation

Current status of graft-versus-host disease after intestinal transplantation

Challenges with Intestine and Multivisceral Re-Transplantation: Importance of Timing of Re-Transplantation and Optimal Immunosuppression

Choice of Allograft in Patients Requiring Intestinal Transplantation: A Critical Review

[Multimodal Approach to Clinical Liver Transplantation].

Outcomes of Combined Liver and Pancreas Transplantation: A Review of the SRTR National Database and a Report of the Largest Single Center Series

33: Living Donor Intestinal Transplantation: a Single-Center Experience

Organ transplantation and gut microbiota: current reviews and future challenges

Combined Organ Transplantation in Patients with Advanced Liver Disease

Multivisceral transplantation utilizing hepatitis C virus-viremic donors for hepatitis C virus-negative recipients

Advances Inliving-Related Small Intestinal Transplantation

Graft‐Versus‐Tumor Effect in Major Histocompatibility Complex–Mismatched Mouse Liver Transplantation

Current Understanding of Marginal Grafts in Liver Transplantation

Successful combined auxiliary partial liver and intestinal transplantation in two highly sensitized, cross-match positive patients.

The current state of tolerance induction in vascularized composite allotransplantation

Full Split Liver Transplantation - Long-Term Follow-Up of a Large Series and Its Applicability in the Recent Transplant Era

Non-composite Combined Liver and Intestinal Allotransplantation.